KLOW Peptide Dosage: What the Blend Contains and How It Is Measured

KLOW is an acronym, not a compound. It names a blend of four separate peptides sold pre-mixed in a single vial: GHK-Cu, KPV, BPC-157 and TB-500. Every dosing question about KLOW is therefore a question about a specific vendor’s mix, because nothing standardises the ratio.

That is the single most important thing to understand before comparing one KLOW vial to another. A “10 mg KLOW” label tells you the total peptide mass and nothing about how that mass is divided.

What is in the vial

Peptide Library catalogues KLOW as GHK-Cu, KPV, BPC-157 and TB-500 — the most common commercial formulation:

Why a single “KLOW dose” cannot exist

Each component has a different research context, a different molecular weight and a different quantity range in the literature. Mixing them fixes their ratio permanently at whatever the manufacturer chose.

• GHK-Cu is the copper-binding tripeptide studied for tissue remodeling and antioxidant effects. It carries copper, which is the reason it is the one component with a genuine ceiling — copper is not a free variable.

• KPV is a three-residue fragment of α-MSH studied in inflammation models, including an oral nanoparticle colitis study. Milligram-for-milligram it is the smallest molecule in the vial, so a fixed mass share is a much larger molar share.

• BPC-157 is a pentadecapeptide with an extensive rodent literature and no completed human trial.

• TB-500 is a synthetic fragment of thymosin beta-4, not the full protein — a distinction vendors routinely blur.

Reconstituting the vial dilutes all four in lockstep. You cannot raise one without raising the others, which is the practical trade-off of buying any blend rather than the individual peptides.

Reading the label: worked example

Suppose a vial is labelled 70 mg total, itemised on the COA as GHK-Cu 30 mg, KPV 10 mg, BPC-157 15 mg, TB-500 15 mg. Add 3 mL of bacteriostatic water and the concentrations become:

Where the blend logic comes from

The rationale offered for KLOW is that its components act on different parts of the same repair and inflammation research picture — GHK-Cu on matrix remodeling, KPV on inflammatory signalling, and the BPC-157/TB-500 pair on tissue repair. GHK-Cu in particular has a genuinely interesting literature on TGF-β secretion in dermal fibroblasts and on oxidative stress.

No study has tested this combination. The individual papers are on individual peptides, mostly in cell culture or rodents. Combining four compounds produces interactions that single-agent studies cannot predict, and there is no published pharmacokinetic work on the mixture. The blend is a commercial construction, not a researched protocol.

Copper is the real constraint

GHK-Cu delivers copper along with the peptide. Copper has a narrow physiological window, and it is the one component of KLOW where the ceiling is set by something other than convention. Blends with a large GHK-Cu share cap how much of the vial can reasonably be used, regardless of what the other three components might otherwise allow.

This is covered in more depth in the GHK-Cu dosage guide and the GHK-Cu side effects guide.

Reconstitution and storage

A blend follows the stability rules of its least stable component, not its most stable. In practice that means treating the reconstituted vial conservatively: 2–8 °C, protected from light, never frozen, and bounded by the 28-day limit on bacteriostatic water. GHK-Cu solutions are also light-sensitive in a way the other three are not.

The reconstitution guide and the storage guide cover the general procedure.

Blend versus components

The COA point is the one most often skipped. Verifying a four-peptide blend requires an analysis that resolves and quantifies all four; a single purity figure for “KLOW” tells you nothing about whether the stated ratio is accurate. The COA reading guide explains what to look for.

What to check before buying

1. An itemised COA. Individual masses for all four components, not a single total.

2. Which four peptides. Confirm the acronym maps to the components you expect.

3. Copper content. GHK-Cu share determines the practical ceiling on the whole vial.

4. Whether TB-500 or thymosin beta-4 is stated — they are not the same molecule.

5. Price per component milligram, not per vial. Compare against buying the four separately using the vendor price comparison.